DE69936533D1 - Neue behandlungsmethode - Google Patents

Neue behandlungsmethode

Info

Publication number
DE69936533D1
DE69936533D1 DE69936533T DE69936533T DE69936533D1 DE 69936533 D1 DE69936533 D1 DE 69936533D1 DE 69936533 T DE69936533 T DE 69936533T DE 69936533 T DE69936533 T DE 69936533T DE 69936533 D1 DE69936533 D1 DE 69936533D1
Authority
DE
Germany
Prior art keywords
treatment method
new treatment
new
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69936533T
Other languages
English (en)
Other versions
DE69936533T2 (de
Inventor
Lisa Benincosa
William Jusko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10842389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69936533(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of DE69936533D1 publication Critical patent/DE69936533D1/de
Publication of DE69936533T2 publication Critical patent/DE69936533T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DE69936533T 1998-11-12 1999-11-12 Neue behandlungsmethode Expired - Lifetime DE69936533T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9824893 1998-11-12
GBGB9824893.3A GB9824893D0 (en) 1998-11-12 1998-11-12 Novel method of treatment
PCT/US1999/026746 WO2000027341A2 (en) 1998-11-12 1999-11-12 Novel method of treatment

Publications (2)

Publication Number Publication Date
DE69936533D1 true DE69936533D1 (de) 2007-08-23
DE69936533T2 DE69936533T2 (de) 2008-03-13

Family

ID=10842389

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69936533T Expired - Lifetime DE69936533T2 (de) 1998-11-12 1999-11-12 Neue behandlungsmethode

Country Status (40)

Country Link
EP (2) EP1759698A1 (de)
JP (1) JP2003521455A (de)
KR (2) KR20070048279A (de)
CN (3) CN1771943A (de)
AP (2) AP2005003432A0 (de)
AR (2) AR029149A1 (de)
AT (1) ATE366573T1 (de)
AU (1) AU768303B2 (de)
BG (2) BG65577B1 (de)
BR (1) BR9915284A (de)
CA (1) CA2350425C (de)
CO (1) CO5150158A1 (de)
CY (1) CY1106892T1 (de)
CZ (1) CZ299801B6 (de)
DE (1) DE69936533T2 (de)
DK (1) DK1135128T3 (de)
DZ (1) DZ2938A1 (de)
EA (2) EA200700968A1 (de)
ES (1) ES2289833T3 (de)
GB (1) GB9824893D0 (de)
HK (1) HK1041202B (de)
HR (1) HRP20010344B1 (de)
HU (1) HUP0104262A3 (de)
IL (1) IL143088A0 (de)
MA (1) MA26759A1 (de)
MY (1) MY128347A (de)
NO (1) NO328391B1 (de)
NZ (1) NZ527132A (de)
OA (1) OA12193A (de)
PE (1) PE20001239A1 (de)
PL (1) PL349421A1 (de)
PT (1) PT1135128E (de)
RS (1) RS50130B (de)
SK (1) SK286357B6 (de)
TR (1) TR200101348T2 (de)
TW (1) TWI234456B (de)
UA (1) UA79730C2 (de)
UY (2) UY25797A1 (de)
WO (1) WO2000027341A2 (de)
ZA (1) ZA200103793B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030920A1 (es) 1999-11-16 2003-09-03 Smithkline Beecham Plc Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
AU2002367154A1 (en) * 2001-12-21 2003-07-15 Smithkline Beecham Corporation Dosing regimen for ppar-gamma activators
WO2012074375A1 (en) * 2010-12-01 2012-06-07 N.V. Nutricia Prevention or treatment of overweight and obesity in type 2 diabetic patients

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
GB8919417D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH0469331A (ja) * 1990-07-10 1992-03-04 Asahi Chem Ind Co Ltd 徐放性エマルジョン製剤
JP2572673B2 (ja) * 1990-07-25 1997-01-16 エスエス製薬株式会社 徐放性錠剤
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
FR2680512B1 (fr) * 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH06510286A (ja) * 1991-08-26 1994-11-17 ファルマシア・アンド・アップジョン・カンパニー 3−グアニジノプロピオン酸およびピオグリタゾン、グリベンクラミドまたはグリメピリドを含有する医薬組成物
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478853A (en) * 1992-10-12 1995-12-26 Adir Et Compagnie Thazolidinedione compounds
US5506245A (en) * 1992-10-12 1996-04-09 Adir Et Compagnie Thiazolidinedione compounds
CA2115587A1 (en) * 1993-02-18 1994-08-19 Hayato Kihara Styrene copolymers, polystyrene compositions, processes for producing styrene copolymers, and injection-molded articles
DE4317320A1 (de) * 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
CZ283339B6 (cs) * 1993-09-15 1998-03-18 Sankyo Company Limited Použití thiazolidinových derivátů pro výrobu léčivého přípravku pro léčení zhoršené tolerance glukosy pro zabránění nebo zpoždění nástupu diabetes mellitus nezávislé na inzulinu
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US5902726A (en) * 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
US5708012A (en) * 1995-04-28 1998-01-13 Sankyo Company, Limited Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
TR200101348T2 (tr) 2002-02-21
BG110061A (bg) 2008-12-30
SK6422001A3 (en) 2001-12-03
OA12193A (en) 2006-05-09
YU37401A (sh) 2005-07-19
AR029317A1 (es) 2003-06-25
UY25801A1 (es) 2000-08-21
EA200700968A1 (ru) 2008-06-30
AR029149A1 (es) 2003-06-18
AP2005003432A0 (en) 2005-12-31
DE69936533T2 (de) 2008-03-13
KR20010080440A (ko) 2001-08-22
DK1135128T3 (da) 2007-11-05
KR20070048279A (ko) 2007-05-08
PL349421A1 (en) 2002-07-29
AU1719600A (en) 2000-05-29
GB9824893D0 (en) 1999-01-06
BG105569A (en) 2002-01-31
HK1041202B (zh) 2007-10-05
EP1135128A4 (de) 2003-07-16
CA2350425A1 (en) 2000-05-18
CY1106892T1 (el) 2012-01-25
EA200100539A1 (ru) 2001-12-24
CN101244062A (zh) 2008-08-20
CN1235586C (zh) 2006-01-11
EP1135128B1 (de) 2007-07-11
WO2000027341A2 (en) 2000-05-18
EP1135128A2 (de) 2001-09-26
UA79730C2 (en) 2007-07-25
EA009192B1 (ru) 2007-12-28
PE20001239A1 (es) 2000-12-24
NZ527132A (en) 2005-01-28
HUP0104262A2 (en) 2002-08-28
NO20012301L (no) 2001-07-09
ATE366573T1 (de) 2007-08-15
WO2000027341A3 (en) 2000-09-08
HRP20010344B1 (en) 2008-02-29
TWI234456B (en) 2005-06-21
JP2003521455A (ja) 2003-07-15
CO5150158A1 (es) 2002-04-29
ZA200103793B (en) 2002-06-05
RS50130B (sr) 2009-03-25
HK1041202A1 (en) 2002-07-05
AU768303B2 (en) 2003-12-04
EP1759698A1 (de) 2007-03-07
BG65577B1 (bg) 2009-01-30
CA2350425C (en) 2009-06-02
ES2289833T3 (es) 2008-02-01
CN1771943A (zh) 2006-05-17
MY128347A (en) 2007-01-31
CZ299801B6 (cs) 2008-11-26
PT1135128E (pt) 2007-10-12
SK286357B6 (sk) 2008-08-05
UY25797A1 (es) 2000-12-29
BR9915284A (pt) 2002-02-13
CZ20011656A3 (cs) 2002-06-12
AP1580A (en) 2006-02-24
CN1354661A (zh) 2002-06-19
NO328391B1 (no) 2010-02-08
DZ2938A1 (fr) 2004-03-15
IL143088A0 (en) 2002-11-10
MA26759A1 (fr) 2004-12-20
HRP20010344A2 (en) 2002-06-30
NO20012301D0 (no) 2001-05-10
HUP0104262A3 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
ID30025A (id) Metode perlakuan tekstil
DE29816175U1 (de) Wasserbehandlungseinrichtung
DE69828821D1 (de) Wasserbehandlungsverfahren
IS8368A (is) Ný aðferð
DK0951447T3 (da) Vandbehandling
DE69938817D1 (de) Erstellungsverfahren
DE69906861D1 (de) Steuermethode
DE60023454D1 (de) Lagenmaterialen mit tensid-modifizierten chelatbildern behandelt
DE69912949D1 (de) Entwässerungsverfahren
ATE236878T1 (de) Neue produktionsmethode
ID28966A (id) Metoda pemurnian trietanolamina
IS5106A (is) Ný aðferð
ID27483A (id) Metoda terapi gen
DE69718808T2 (de) Plasmabehandlungsmethode
IS4789A (is) Meðferðarefnasambönd
ID19570A (id) Metode merawat tanaman kotiledonous
NO20006531D0 (no) Kontrollmetode
DE69708229T2 (de) Muster-Herstellungsverfahren
DE69500952D1 (de) Solebehandlungsmethode
DE69936533D1 (de) Neue behandlungsmethode
ID16924A (id) Metode perlakuan poliolefin
DE69903035D1 (de) Erwärmungsverfahren
DE29823166U1 (de) Massageeinrichtung
DE19883020T1 (de) Entladungsoberflächen-Behandlungsverfahren
FI991128A0 (fi) Päällystysmenetelmä

Legal Events

Date Code Title Description
8364 No opposition during term of opposition